New medications are on the horizon, like those combining GLP-1 with other hormones (like amylin), oral versions that could compete with injectable semaglutide, and even triple-action drugs
Historical Redlining, Socioeconomic Distress, and Risk of Heart Failure Among Medicare Beneficiaries
486 Nrf2 can activate the transcription of a series of antioxidant genes and block ferroptosis, playing a protective role in DOX-induced cardiomyopathy by regulating oxidative stress and autophagy
Abstract Purpose of Review The aim of this review is to provide a comprehensive summary of current clinical evidence on the relationship between GLP-1 receptor agonists and pediatric obesity, to evaluate these findings from metabolic and therapeutic perspectives, and to offer potential directions for future research in the field
Data analysis Given the broad range of conditions and outcomes assessed, all outcome indicators were categorized a priori by clinical system to facilitate a structured synthesis and interpretation
Reach your weight loss goals with proper care and effective treatments